Common Stock Reserved For Issuance (Tables)

12 Months Ended

Dec. 31, 2019

Equity [Abstract]

Common Stock Reserved for Potential Future Issuances

Common stock has been reserved for the following potential future issuances:

	As of December 31, 2019		As of December 31, 2018
Shares underlying outstanding stock options		579,731		405,683
Shares available for future stock option grants		230,952		423,000
Exchange of Vaccinex Products, LP units		1,173,500		1,202,566
Conversion of VX3 units		1,318,797		1,318,797
Total shares of common stock reserved		3,302,980		3,350,046